NASDAQ
3.27USD
-0.07 (-2.10%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.1B
P/E
—
EPS
—
Beta
1.61
52W range
1.77-5.81
Day range
3.21–3.36
Open
3.33
Prev close
3.34
Volume
2M
Avg volume
1.4M
Dividend
0.00
IPO
2020-09-23
https://www.zacks.com/stock/news/2969416/goodrx-holdings-inc-gdrx-q2-earnings-match-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2969416 · 8/6/2026+0.10
https://www.zacks.com/stock/news/2939788/biodesix-bdsx-surges-10-5-is-this-an-indication-of-further-gains?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_5%-2939788 · 6/19/2026+0.20
https://seekingalpha.com/article/4907087-goodrx-trumprx-exposes-legacy-moat-breach-and-zero-sum-strategy-downgrade · 5/20/2026-0.70
https://www.zacks.com/stock/news/2884757/hims-expands-personalized-digital-healthcare-access-and-services?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2884757 · 3/16/2026+0.60
https://www.zacks.com/stock/news/2836897/hims-hers-strengthens-platform-led-digital-healthcare-model?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2836897 · 2/6/2026
https://www.cnbc.com/2026/01/09/amazon-pharmacy-starts-offering-novo-nordisks-wegovy-weight-loss-pill.html · 1/9/2026+0.10
https://www.businesswire.com/news/home/20260105738223/en/GoodRx-Now-Offers-Novo-Nordisk%E2%80%99s-Cash-Price-for-the-Launch-of-the-Wegovy%C2%AE-Pill/ · 1/5/2026+0.60
https://www.reuters.com/business/healthcare-pharmaceuticals/goodrx-expands-tie-up-with-kroger-offer-branded-drugs-discounted-price-2025-10-01/ · 10/1/2025+0.60
https://www.businesswire.com/news/home/20251001520800/en/GoodRx-Launches-Brand-Medication-Savings-Program-at-National-Retail-Pharmacy/ · 10/1/2025+0.80
https://seekingalpha.com/article/4823289-goodrx-renewed-chance-to-sign-up-new-customers · 9/16/2025+0.40
https://seekingalpha.com/article/4814594-goodrx-after-a-30-percent-surge-on-the-novo-news-is-the-story-just-beginning · 8/18/2025+0.90
https://www.barrons.com/articles/goodrx-stock-novo-nordisk-ozempic-97cc924d · 8/18/2025+0.50
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
